- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07350902
Impact of Primary Dysmenorrhea on Academic Performance and Quality of Life Among Medical Students at Sohag University
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In the world, the estimated prevalence of dysmenorrhea ranges from 45% to 93% of women of reproductive age, with adolescents having the highest rates of dysmenorrhea.
Studies suggest that approximately 140 million hours are lost annually from school or work owing to dysmenorrhea. It is a leading cause of recurrent short-term school absenteeism, lack of concentration, no active participation, inability to do homework, failure in an exam, and limitation of activity.
An estimated 15% of adolescent females describe their pain as severe, impacting their quality of life. These adolescents can miss 1 to 3 days of school per menstrual cycle.
Studies have noted that dysmenorrhea can lead to lower academic performance (AP) and poor quality of sleep, resulting in mood changes, such as anxiety and depression
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Amira Fayez, Ass.lecturer
- Phone Number: 01279954256
- Email: amerahfayez@med.sohag.edu.eg
Study Contact Backup
- Name: Shimaa Harris, lecturer
- Phone Number: 01098626250
- Email: shimaa.hares@med.sohag.edu.eg
Study Locations
-
-
-
Sohag, Egypt
- Sohag University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
A cross-sectional survey will be conducted in three randomly chosen faculties' in Sohag University,
The sample will be selected as follow:
- 3 medical faculties were selected randomly. [Faculty of Medicine, and faculty of Nursing] medical female students are the study population
- Students will be selected by stratified random sampling technique.
- Students from each grade except the first grade will be selected by using random sampling technique after fulfilling the eligibility criteria.
Description
Inclusion Criteria:
- • Undergraduate females from the 3 selected faculties in Sohag University
Exclusion Criteria:
• Students who will refuse to participate in this study.
- Pregnant females \ females with amenorrhea.
- Females with gynecological problems as adenomyosis, uterine fibroids and others to exclude secondary dysmenorrhea
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The WaLIDD questionnaire
Time Frame: December 2027
|
The WaLIDD questionnaire contains 4 questions : Working ability = 0: never, 1: sometimes, 2: regularly, 3: always; Location = 0: none, 1: 1 location. 2: 2-3 locations, 3: 4 locations; Intensity = 0: never, 1: sometimes, 2: regularly, 3: always; Day of Pain = 0: none, 1: 1-2 days, 2: 3-4 days, 3: more than 5 days So, Each of the four questions is scored from 0 to 3 Total score: The total score ranges from 0 to 12 The interpretation of the WaLIDD questionnaire is as follows: 0 = No Dysmenorrhea 1-4 = Mild Dysmenorrhea 5-7 = Moderate Dysmenorrhea 8-12 = Severe Dysmenorrhea |
December 2027
|
|
"DysmenQoL questionnaire" (dysmenorrhea and quality of life)
Time Frame: December 2027
|
it is represented by 20 statements about the negative effects of dysmenorrhea on quality of life (effects on health and feelings, relationships with family members or friends, couple relationships and professional activity). It consists of twenty statements ,the participants give a score from 1 to 5 for each statement: 1-"Never"; 2-"Few cases"; 3-"Sometimes"; 4-"Most of the time" ; 5-"Every time". We calculate the sum of the scores for each statement and we call it "DysmenQoL score" whose value could vary between 20 and 100. So, high scores indicate low quality of life. The DysmenQoL questionnaire proved to be a reliable and valid method for evaluating the impact of dysmenorrhea on the quality of life. |
December 2027
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Amira Fayez Shenouda, Ass lecturer, Faculty of Medicine, Sohag University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med--25-12-1MD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Dysmenorrhea
-
Ankara UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruiting
-
University of SharjahNot yet recruiting
-
Cairo UniversityRecruitingPrimary DysmenorrheaEgypt
-
Cairo UniversityCompletedPrimary DysmenorrheaEgypt
-
Camilo Jose Cela UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingPrimary DysmenorrheaEgypt
-
Rana Salem Abdelghany AliCompletedPrimary DysmenorrheaEgypt
-
University of HailHealth Education Research Foundation (HERF)Recruiting
-
Dr. Mehak NaeemUniversity of Health Sciences LahoreRecruiting
-
ApexCPG LLCNot yet recruitingPrimary Dysmenorrhea | Menstural CrampsIndia
Clinical Trials on self administered questionnaire
-
University Hospital, LilleFondation Santé RoquetteCompleted
-
Alaa Mohammed YehiaCompletedMolar Incisor Hypomineralization | Dental Enamel HypoplasiaEgypt
-
Centre Hospitalier Intercommunal CreteilNot yet recruitingSquamous Cell Carcinoma of the Anal Canal | HPV-induced Cancer
-
Central Hospital, Nancy, FranceCompletedAtopic DermatitisFrance
-
University Hospital, BordeauxRecruitingSpinal Stenosis | Vertebral Osteomyelitis | SPINAL Fracture | Vertebral MetastasisFrance
-
Sohag UniversityNot yet recruitingQuality of Life | Health Anxiety
-
University Hospital, BordeauxRecruitingInflammatory Bowel Diseases | Crohn Disease | Ulcerative ColitisFrance
-
Centre Hospitalier Charles Perrens, BordeauxRégion Nouvelle Aquitaine; Regional Health Agency New AquitaineNot yet recruitingCovid19 | Work-Related Condition | Work-Related Stress Disorder | Personnel, Hospital
-
University Hospital, MontpellierTerminated